List of Ongoing Clinical Trial - Wan Fang Hospital
Symptom
|
IRB NO.
|
Clinical trial title
|
Principal Investigator
|
Department
|
Assistant Phone
|
Femtosecond Ophthalmic
|
N202005019
|
Intracorneal Lenticular Extraction refractive surgery with Femtosecond Ophthalmic laser Femton F1
|
Chien-Liang
Wu
|
Ophthalmology
|
Hsiu-Yen
Wang
0229307930#2543
|
Femtosecond Ophthalmic
|
N202005020
|
Femtosecond FLEX Application with
|
Chien-Liang
Wu
|
Ophthalmology
|
Hsiu-Yen
Wang
0229307930#2543
|
Lung Cancer
|
N202107070
|
A Prospective, Randomized, Open-Label, Add-On, Parallel Control Study to Investigate Safety and Efficacy of the cold water extract of Arthrospira maxima in Patients with Ambulatory Mild and Moderated Disease COVID-19
|
Fu-Lun Chen
|
Infection
|
Hsiu-Yen
Wang
0229307930#2543
|
COVID-19
|
N202306066
|
A Randomized, Double blind Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Resected Stage III or Stage IV Melanoma Subjects in the Adjuvant Setting
|
Chia-Lun Chang
|
Hematology
and Oncology
|
Wei-Ling
Zhou
0914019869
|
Cell Therapy
|
N202305080
|
ARTEMIS: Ravulizumab To Protect Patients With Chronic Kidney Disease (CKD) From Cardiac Surgery Associated Acute Kidney Injury (CSA AKI) And Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
|
Chun-Che Shih
|
Cardiovascular Surgery
|
Sih-Chen
Wang
0958131385
|
Tibial fracture
|
N202301037
|
A Phase I, Open-label, Dose-escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Modified Salmonella Typhimurium SGN1 Administered via Intratumoral Injection in Patients with Advanced Solid Tumors
|
Chia-Lun Chang
|
Hematology and Oncology
|
Wei-Ling
Zhou
0914019869
|
Chronic Kidney Disease
|
N202206025
|
Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
|
Jia-Ying Sung
|
Neurology
|
Hsiu-Chen
Chang
0229307930#2550
|
Hypertension
|
N202204010
|
A randomized, evaluator-blinded, controlled study to evaluate the safety and clinical performance of OIF/β-TCP in patients with open tibial fractures in need of bone grafting.
|
Yi-Jie
Kuo
|
Orthopedics
|
Hsiu-Chen
Chang
0229307930#2550
|
Pancreatic Cancer
|
N202108058
|
Develop the umbilical cord mesenchymal stem cell model from human umbilical cord
|
Le-Ming Wang
|
Obstetrics/
Gynecology
|
Yi-Jie
Ding
02-89797888#118
|
Acute Respiratory Syncytial Virus Infection
|
N202207016
|
A Multicentre, Randomized, Double-blind Study to Evaluate and Compare the Efficacy and Safety of 8-week Treatment with Azilsartan Medoxomil and Amlodipine Besylate Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects
|
Ming-Hsiung Hsieh
|
Cardiology
|
Sih-Chen
Wang
0958131385
|
Solid tumors
|
N202208004
|
A Phase 2, Open-Label, Randomized Study to Assess the Efficacy and Safety of Zolbetuximab (IMAB362) in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
|
Tzeon-Jye Chiou
|
Hematology and Oncology
|
Sih-Chen
Wang
0958131385
|
Viral Lung Infection Requiring Supplemental Oxygen
|
N202005024
|
Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Efficacy of DZD9008 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR or HER2 mutation
|
Chia-Lun Chang
|
Hematology and Oncology
|
Wei-Ling
Yang
0229307930#2556
|
Chronic Kidney Disease
|
N202302038
|
A Phase III, Multicentre, Randomised, Double blind, Parallel group, Placebo controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)
|
Tsong-Yih Ou
|
Infection
|
Hsiu-Chen
Chang
0229307930#2550
|
Melanoma
|
N202301029
|
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults with Acute Respiratory Syncytial Virus Infection who are at High Risk for Complications
|
Tsong-Yih Ou
|
Infection
|
Hsiu-Chen
Chang
0229307930#2550
|